English
Trade
Wanbury share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹242.80(0.68%)November 12, 2025 15:25:59 PM IST
- NSE
- BSE
- Vol : 30.95K (NSE + BSE)Last 20 day avg : 104.85 K
Wanbury is trading 0.68% upper at Rs 242.80 as compared to its last closing price. Wanbury has been trading in the price range of 247.00 & 241.00. Wanbury has given -16.43% in this year & -7.42% in the last 5 days. Wanbury has TTM P/E ratio 21.40 as compared to the sector P/E of 29.66.The company posted a net profit of 13.49 Crores in its last quarter.Listed peers of Wanbury include Aayush Wellness (-0.08%), Fermenta Biotech (6.54%), Wanbury (0.68%).The Mutual Fund holding in Wanbury was at -% in . The MF holding has - from the last quarter. The FII holding in Wanbury was at 0.80% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Nov 12, 2025, 09:00 PM UTC
- BetaHigh volatility1.34Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry2.98The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Wanbury News
Wanbury Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is profitable- The company's revenue grew in June quarter by 24.47% from Rs 163.18 crore to Rs 131.11 crore, year-on-year
- The company has grown its June quarter profit by 1200.41% from Rs 1.04 crore to Rs 13.49 crore, year-on-year
The debt to equity of the company is higher than the industry median- Company can comfortably pay off its interest obligations with its earnings
Wanbury Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 278.30
- R2
- 293.10
- R3
- 311.75
Pivot259.65
- S1
- 244.85
- S2
- 226.20
- S3
- 211.40
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Wanbury Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Aayush Wellness | Bearish | 37.80 | -0.08 | 183.98 | 311.96 | 126.51 | - | 0.55 |
| Fermenta Biotech | Neutral | 285.00 | 6.54 | 838.78 | 12.57 | 2.66 | 0.75 | 5.37 |
| Wanbury | Bearish | 242.80 | 0.68 | 798.75 | 30.92 | 15.35 | - | 271.82 |
| Kopran | Bearish | 151.20 | -5.03 | 726.89 | 22.76 | 1.69 | 1.65 | 3.18 |
| Bharat Parenterals | Bearish | 1,138.95 | 3.79 | 784.96 | - | 2.5 | 0.08 | 22.94 |
Wanbury Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Wanbury is currently unavailable
Please check back later.
Shareholding Insights
- Pledged found - Promoter(s) have pledged 71.73% of shares.
- Promoter(s) have increased pledged shares to 62.18% from 71.73% earlier.
- Promoter(s) holding is moderate at 39.63%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has decreased by 0.02 percentage points from previous quarter
- Mutual Funds are not invested in this company.
Wanbury Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-13 | Quarterly Results |
| 2025-08-04 | Quarterly Results |
| 2025-05-15 | Audited Results |
| 2025-02-12 | Quarterly Results & Others |
| 2024-11-13 | Quarterly Results |
About the company Wanbury
- IndustryBiotechnology & Drugs
- ISININE107F01022
- BSE Code524212
- NSE CodeWANBURY
Wanbury Limited is an India-based pharmaceutical company with a presence in the active pharmaceutical ingredients (APIs) global market and domestic branded formulations. The Company is engaged in the business of pharmaceutical and related activities, including research. Its API products include Metformin, Metformin Dc, Tramadol, Sertraline, Diphenhydramine HCL, Diphenhydramine Citrate, Mefenamic Acid, Paroxetine Hemihydrate, Promethazine, Glucosamine, Clopidogrel, Levetiracetam and Carvedilol Phosphate Monohydrate. In formulations, the Company has a presence across various therapeutic categories, such as cough and cold solutions, gynecology, orthopedics, nutraceuticals, gastrointestinal, anti-inflammatory and analgesics. The Company is also focused on the development of products like ketamine, rivaroxaban, montelukast, sitagliptin and a few others to reduce dependency on metformin and sertraline. The Company has facilities in Tanuku, Andra Pradesh, and Patalganga, Maharashtra.
Wanbury Share Price FAQs
Wanbury is trading at 242.80 as on Wed Nov 12 2025 09:55:59. This is 0.68% upper as compared to its previous closing price of 241.15.
The market capitalization of Wanbury is 798.75 Cr as on Wed Nov 12 2025 09:55:59.
The 52 wk high for Wanbury is 330.00 whereas the 52 wk low is 155.00
Wanbury can be analyzed on the following key metrics -
- TTM P/E: 21.40
- Sector P/E: 29.66
- Dividend Yield: 0.00%
- D/E ratio: -
Wanbury reported a net profit of 30.53 Cr in 2025.
Quick Links